Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page history now includes a new Revision: v3.6.4 entry. The previous Revision: v3.6.3 has been removed, updating the page's revision metadata.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedA new Revision: v3.6.3 entry has been added to the history and the previous Revision: v3.6.2 entry has been removed, representing an updated software version tag in the record history.SummaryDifference0.0%

- Check39 days agoChange DetectedThe record update shows the study has completed and has a refreshed revision, replacing the previous Active, not recruiting status as part of the update.SummaryDifference0.4%

- Check53 days agoChange DetectedThe study record now indicates that no participants are being sought, signaling that recruitment for this trial has ended. The record has been updated to Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check60 days agoChange DetectedThe history now shows Revision: v3.5.5 as the latest entry, and the previous Revision: v3.5.4 is no longer listed.SummaryDifference0.1%

- Check82 days agoChange DetectedThe history shows a new revision v3.5.4 added and the previous revision v3.5.3 removed, indicating the study record has been refreshed to the latest version.SummaryDifference0.1%

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.